Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
15 Mars 2021 - 12:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For March 2021
Commission File No. 001-36848
Check-Cap Ltd.
Check-Cap Building
Abba Hushi Avenue
P.O. Box 1271
Isfiya, 30090
Mount Carmel, Israel
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
The first and third paragraphs and the “Forward Looking Statements” of the press release attached to this Form 6-K are
being incorporated by reference into the Post-Effective Amendment No. 1 to the Form S-8 Registration Statement File No. 333-203384, Form S-8 Registration Statement File No. 333-226490, and into the Form F-3 Registration Statements File Nos. 333-211065
and 333-225789.
On March 15, 2021, Check-Cap Ltd. issued a press release entitled “Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan(R)”.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Exhibit
|
|
|
|
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
|
Check-Cap Ltd.
|
|
|
|
|
By:
|
/s/ Alex Ovadia
|
|
|
Name: Alex Ovadia
|
Date: March 15, 2021
|
|
Title: Chief Executive Officer
|
Check Cap (NASDAQ:CHEK)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Check Cap (NASDAQ:CHEK)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025